ANIK
Anika Therapeutics Inc
Price:  
10.53 
USD
Volume:  
87,305.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Anika Relative Valuation

-606.4%
Upside

As of 2025-07-02, the Relative Valuation of Anika Therapeutics Inc (ANIK) is (53.32) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.53 USD, the upside of Anika Therapeutics Inc based on Relative Valuation is -606.4%.

The range of the Relative Valuation is (39.17) - (63.71) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 9.0x - 16.1x 13.0x
Forward P/E multiples 9.9x - 19.6x 14.0x
Fair Price (39.17) - (63.71) (53.32)
Upside -472.0% - -705.0% -606.4%
10.53 USD
Stock Price
(53.32) USD
Fair Price

Anika Relative Valuation - Historical P/E Data

Date P/E
2025-06-30 -2.67
2025-06-27 -2.71
2025-06-26 -2.74
2025-06-25 -2.81
2025-06-24 -2.84
2025-06-23 -2.76
2025-06-20 -2.68
2025-06-18 -2.81
2025-06-17 -2.79
2025-06-16 -2.81
2025-06-13 -2.76
2025-06-12 -2.85
2025-06-11 -2.86
2025-06-10 -2.92
2025-06-09 -2.91
2025-06-06 -2.87
2025-06-05 -2.83
2025-06-04 -2.94
2025-06-03 -2.93
2025-06-02 -2.89
2025-05-30 -2.82
2025-05-29 -2.85
2025-05-28 -2.81
2025-05-27 -2.82
2025-05-23 -2.84
2025-05-22 -2.97
2025-05-21 -2.96
2025-05-20 -3.02
2025-05-19 -3.07
2025-05-16 -3.08
2025-05-15 -3.09
2025-05-14 -2.86
2025-05-13 -3.14
2025-05-12 -2.99
2025-05-09 -2.94
2025-05-08 -3.73
2025-05-07 -3.66
2025-05-06 -3.56
2025-05-05 -3.66
2025-05-02 -3.75
2025-05-01 -3.65
2025-04-30 -3.67
2025-04-29 -3.71
2025-04-28 -3.67
2025-04-25 -3.65
2025-04-24 -3.63
2025-04-23 -3.56
2025-04-22 -3.59
2025-04-21 -3.55
2025-04-17 -3.54